Search - tctmd.com

Displaying 101 - 120 of 1738

Sort: Relevancy | Date

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration

Presenter: Steven E. Nissen

April 08, 2024

Presentation ACC 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presenter: David E. Kandzari

April 08, 2024

Presentation ACC 2024

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

Presenter: David Austin

April 08, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presentation ACC 2024

Primary Results from the Phase 2 KARDIA-2 Study

Presenter: Akshay Desai

April 07, 2024

Presentation ACC 2024

Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial

Presenter: Alexander Fanaroff

April 07, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation ACC 2024

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Presenter: Michael J. Koren

April 06, 2024

Presentation ACC 2024

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Presenter: Ronald Chi Hang Lee

April 06, 2024

Presentation ACC 2024

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

Presenter: Yousuf Razvi

April 06, 2024

Presentation THT Abstracts 2024

Beyond Supine Pulmonary Artery Pressures

Presenter: Marat Fudim

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Presentation THT Abstracts 2024

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Presenter: Rebecca Steinberg

March 05, 2024

Presentation THT 2024

Basic Science for the Clinician: Overview

Presenter: Steven O. Marx

March 05, 2024

Presentation THT 2024

GPx -- Bloodless Blood Tests

Presenter: Javier Echenique

March 05, 2024

Presentation THT 2024

AI in Diagnostics and Therapeutics: Horizons Ahead

Presenter: Harlan Krumholz

March 05, 2024

Presentation THT Abstracts 2024

Utilization of Portable Exercise Bikes and Its Effect on Walking Distance After Cardiac Surgery

Presenter: Ghadi Moubarak

March 04, 2024

Presentation THT 2024

Advances in Hemocompatibility

Presenter: Mandeep R. Mehra

March 04, 2024

Advertisement

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Evaluation of a Technology Assisted Web Application to Qualify for Nonprescription Statin Administration

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Primary Results from the Phase 2 KARDIA-2 Study

Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Main Results From The Step-hfpef Dm Trial

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

Beyond Supine Pulmonary Artery Pressures

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Basic Science for the Clinician: Overview

GPx -- Bloodless Blood Tests

AI in Diagnostics and Therapeutics: Horizons Ahead

Utilization of Portable Exercise Bikes and Its Effect on Walking Distance After Cardiac Surgery

Advances in Hemocompatibility

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content